Proteomics Research in Cardiovascular Medicine and Biomarker Discovery
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Proteomics is a systems physiology discipline to address the large-scale characterization of protein species within a biological system, be it a cell, a tissue, a body biofluid, an organism, or a cohort population. Building on advances from chemical analytical platforms (e.g., mass spectrometry and other technologies), proteomics approaches have contributed powerful applications in cardiovascular biomedicine, most notably in: 1) the discovery of circulating protein biomarkers of heart diseases from plasma samples; and 2) the identification of disease mechanisms and potential therapeutic targets in cardiovascular tissues, in both preclinical models and translational studies. Contemporary proteomics investigations offer powerful means to simultaneously examine tens of thousands of proteins in various samples, and understand their molecular phenotypes in health and disease. This concise review introduces study design considerations, example applications and use cases, as well as interpretation and analysis of proteomics data in cardiovascular biomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
O'Leary, N. A., Wright, M. W., Brister, J. R., Ciufo, S., Haddad, D., McVeigh, R., Rajput, B., Robbertse, B., Smith-White, B., Ako-Adjei, D., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1189 · Cited by 6,357
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
On the Dependency of Cellular Protein Levels on mRNA Abundance
Liu, Y., Beyer, A., & Aebersold, R. (2016) · Cell · doi:10.1016/j.cell.2016.03.014 · Cited by 3,221 · cited 1×
“Although the exact contribution of transcripts to protein-level abundance is debated, it is evident that in the heart and other organs, a large number of post-transcriptional modulators can alter disease-driver protein expression and function during pathogenesis, without changes in transcript abundance (9,10).”
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867 · cited 3×
“Thus, individual putative protein markers often require lengthy verification and validation pipelines that involve large cohorts (83).”
BackgroundInfluentialProteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Protein Analysis by Shotgun/Bottom-up Proteomics
Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., & Yates, J. R. (2013) · Chemical Reviews · doi:10.1021/cr3003533 · Cited by 1,491 · cited 1×
“A major strength of shotgun proteomics is that it casts the widest net toward potential biomarkers (covering thousands of proteins) (22) and does not require the development of individual assays for each target (23,24).”
The BioPlex network: a systematic exploration of the human interactome
Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.043 · Cited by 1,425 · cited 4×
“Although it is the current mainstay of interactome research, AP-MS specificity can vary.”
InfluentialC-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Vogel, C., de Sousa Abreu, R., Ko, D., Le, S., Shapiro, B. A., Burns, S. C., Sandhu, D., Boutz, D. R., Marcotte, E. M., & Penalva, L. O. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.59 · Cited by 608
Defining the transcriptome and proteome in three functionally different human cell lines
Lundberg, E., Fagerberg, L., Klevebring, D., Matic, I., Geiger, T., Cox, J., Älgenäs, C., Lundeberg, J., Mann, M., & Uhlen, M. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.106 · Cited by 373
Ganz, P., Heidecker, B., Hveem, K., Jonasson, C., Kato, S., Segal, M. R., Sterling, D. G., & Williams, S. A. (2016) · JAMA · doi:10.1001/jama.2016.5951 · Cited by 364 · cited 3×
“, antibodyand aptamer-based arrays) (31,33,34), are being used to discover candidate biomarkers.”
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Lee, D. I., Zhu, G., Sasaki, T., Cho, G.-S., Hamdani, N., Holewinski, R., Jo, S.-H., Danner, T., Zhang, M., Rainer, P. P., et al. (2015) · Nature · doi:10.1038/nature14332 · Cited by 353 · cited 1×
“, those targeted by phosphodiesterase 9A/phosphodiesterase 5, calcium/ calmodulin-dependent protein kinase II) (59,60), specific proteins (e.”
Labugger, R., Organ, L., Collier, C., Atar, D., & Van Eyk, J. E. (2000) · Circulation · doi:10.1161/01.cir.102.11.1221 · Cited by 315 · cited 1×
“O ver the past 20 years, there has been accelerating growth in the application of proteomics in cardiovascular biomedicine, building on pioneering studies with translational significance (1,2) and mechanistic insights (3–8).”
Systems proteomics of liver mitochondria function
Williams, E. G., Wu, Y., Jha, P., Dubuis, S., Blattmann, P., Argmann, C. A., Houten, S. M., Amariuta, T., Wolski, W., Zamboni, N., et al. (2016) · Science · doi:10.1126/science.aad0189 · Cited by 289 · cited 1×
“Proteogenomics studies, combining RNA-seq and proteomics data from common datasets, have been undertaken in cancer research to identify the protein coding consequences of cancer variants and mutations (91), whereas a recent multiomics study in 80 mouse genetic backgrounds demonstrated that multiple types of omics data…”
BackgroundAbbatiello, S. E., Schilling, B., Mani, D. R., Zimmerman, L. J., Hall, S. C., MacLean, B., Albertolle, M., Allen, S., Burgess, M., Cusack, M. P., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.047050 · Cited by 215 · cited 1×
“Proteomics assays have reported typical coefficients of variation in the range of <5% for intralaboratory measurements (34,84) to <20% for interlaboratory measurements (85).”
Ge, Y., Rybakova, I. N., Xu, Q., & Moss, R. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813369106 · Cited by 154
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
Gerstein, H. C., Paré, G., McQueen, M. J., Haenel, H., Lee, S. F., Pogue, J., Maggioni, A. P., Yusuf, S., & Hess, S. (2015) · Circulation · doi:10.1161/circulationaha.115.015744 · Cited by 69 · cited 3×
“, antibodyand aptamer-based arrays) (31,33,34), are being used to discover candidate biomarkers.”
Research works printed but not linked: 92
- McDonough, 2001, Cardiac troponin I is modified in the myocardium of bypass patients, Circulation, 103, 58, 10.1161/01.CIR.103.1.58 · DOI · Paper page
- Weekes, 1999, Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy, Electrophoresis, 20, 898, 10.1002/(SICI)1522-2683(19990101)20:4/5<898::AID-ELPS898>3.0.CO;2-B · doi:10.1002/(sici)1522-2683(19990101)20:4/5<898::aid-elps898>3.0.co;2-b
- Ping, 2001, Functional proteomic analysis of protein kinase C ε signaling complexes in the normal heart and during cardioprotection, Circ Res, 88, 59, 10.1161/01.RES.88.1.59 · DOI · Paper page
- Edmondson, 2002, Protein kinase C ε signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS, Mol Cell Proteomics, 1, 421, 10.1074/mcp.M100036-MCP200 · DOI
- Lindsey, 2006, A multidimensional proteomic approach to identify hypertrophy-associated proteins, Proteomics, 6, 2225, 10.1002/pmic.200500013 · doi:10.1002/pmic.200500013
- Sun, 2006, Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel α1 subunit and reduced ischemia/reperfusion injury, Circ Res, 98, 403, 10.1161/01.RES.0000202707.79018.0a · DOI · Paper page
- Larance, 2015, Multidimensional proteomics for cell biology, Nat Rev Mol Cell Biol, 16, 269, 10.1038/nrm3970 · DOI · Paper page
- Tian, 2004, Integrated genomic and proteomic analyses of gene expression in mammalian cells, Mol Cell Proteomics, 3, 960, 10.1074/mcp.M400055-MCP200 · DOI · Paper page
- Marshall, 2014, Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes, Am J Physiol Cell Physiol, 306, C639, 10.1152/ajpcell.00167.2013 · DOI
- Van Eyk, 2001, Proteomics: unraveling the complexity of heart disease and striving to change cardiology, Curr Opin Mol Ther, 3, 546
- Nanjappa, 2014, Plasma Proteome Database as a resource for proteomics research: 2014 update, Nucleic Acids Res, 42, D959, 10.1093/nar/gkt1251 · DOI · Paper page
- Pundir, 2015, Searching and navigating UniProt databases, Curr Protoc Bioinformatics, 50, 1.27.1, 10.1002/0471250953.bi0127s50 · DOI
- Kusebauch, 2014, Using PeptideAtlas, SRMAtlas, and PASSEL: comprehensive resources for discovery and targeted proteomics, Curr Protoc Bioinformatics, 46, 13.25.1, 10.1002/0471250953.bi1325s46 · DOI · Paper page
- Zong, 2013, Integration of cardiac proteome biology and medicine by a specialized knowledgebase, Circ Res, 113, 1043, 10.1161/CIRCRESAHA.113.301151 · DOI
- Riley, 2016, Proteomics moves into the fast lane, Cell Syst, 2, 142, 10.1016/j.cels.2016.03.002 · DOI
- Bensimon, 2012, Mass spectrometry-based proteomics and network biology, Annu Rev Biochem, 81, 379, 10.1146/annurev-biochem-072909-100424 · DOI · Paper page
- Keshishian, 2009, Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution, Mol Cell Proteomics, 8, 2339, 10.1074/mcp.M900140-MCP200 · DOI · Paper page
- Lam, 2013, Site-specific quantitative analysis of cardiac mitochondrial protein phosphorylation, J Proteomics, 81, 15, 10.1016/j.jprot.2012.09.015 · DOI
- Zhang, 2012, Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart, Circulation, 126, 1828, 10.1161/CIRCULATIONAHA.112.096388 · DOI · Paper page
- Percy, 2015, Precise quantitation of 136 urinary proteins by LC/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and/or verification studies, Methods, 81, 24, 10.1016/j.ymeth.2015.04.001 · DOI
- Fu, 2016, Multiple and selective reaction monitoring using triple quadrupole mass spectrometer: preclinical large cohort analysis, Methods Mol Biol, 1410, 249, 10.1007/978-1-4939-3524-6_15 · DOI
- Percy, 2013, Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation, Expert Rev Proteomics, 10, 567, 10.1586/14789450.2013.856763 · DOI
- Sajic, 2015, Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications, Proteomics Clin Appl, 9, 307, 10.1002/prca.201400117 · DOI · Paper page
- Ngo, 2016, Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease, Circulation, 134, 270, 10.1161/CIRCULATIONAHA.116.021803 · DOI · Paper page
- Lind, 2015, Discovery of new risk markers for ischemic stroke using a novel targeted proteomics chip, Stroke, 46, 3340, 10.1161/STROKEAHA.115.010829 · DOI
- Sabatine, 2016, Using aptamer-based technology to probe the plasma proteome for cardiovascular disease prediction, JAMA, 315, 2525, 10.1001/jama.2016.6110 · DOI
- Gramolini, 2016, Identifying low-abundance biomarkers: aptamer-based proteomics potentially enables more sensitive detection in cardiovascular diseases, Circulation, 134, 286, 10.1161/CIRCULATIONAHA.116.022940 · DOI
- Keshishian, 2015, Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury, Mol Cell Proteomics, 14, 2375, 10.1074/mcp.M114.046813 · DOI · Paper page
- Cominetti, 2016, Proteomic biomarker discovery in 1000 human plasma samples with mass spectrometry, J Proteome Res, 15, 389, 10.1021/acs.jproteome.5b00901 · DOI · Paper page
- Olsen, 2013, Status of large-scale analysis of post-translational modifications by mass spectrometry, Mol Cell Proteomics, 12, 3444, 10.1074/mcp.O113.034181 · DOI · Paper page
- Huang, 2016, dbPTM 2016: 10-year anniversary of a resource for post-translational modification of proteins, Nucleic Acids Res, 44, D435, 10.1093/nar/gkv1240 · DOI · Paper page
- Thingholm, 2006, Highly selective enrichment of phosphorylated peptides using titanium dioxide, Nat Protoc, 1, 1929, 10.1038/nprot.2006.185 · DOI · Paper page
- Lundby, 2013, In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling, Sci Signal, 6, rs11, 10.1126/scisignal.2003506 · DOI · Paper page
- Schechter, 2014, Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure, PLoS One, 9, e104157, 10.1371/journal.pone.0104157 · DOI
- Karamanlidis, 2013, Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure, Cell Metab, 18, 239, 10.1016/j.cmet.2013.07.002 · DOI · Paper page
- Nguyen, 2013, Cyclophilin D modulates mitochondrial acetylome, Circ Res, 113, 1308, 10.1161/CIRCRESAHA.113.301867 · DOI
- Yang, 2015, SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases, Proteomics, 15, 1181, 10.1002/pmic.201400298 · DOI
- Barallobre-Barreiro, 2016, Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation, Circulation, 134, 817, 10.1161/CIRCULATIONAHA.115.016423 · DOI
- Parker, 2011, Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment, Mol Cell Proteomics, 10, 10.1074/mcp.M110.006833 · DOI
- Wang, 2011, Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy, Circ Res, 109, 750, 10.1161/CIRCRESAHA.111.246124 · DOI · Paper page
- Kohr, 2012, Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication, Circ Res, 111, 1308, 10.1161/CIRCRESAHA.112.271320 · DOI · Paper page
- Zong, 2014, Lysine ubiquitination and acetylation of human cardiac 20S proteasomes, Proteomics Clin Appl, 8, 590, 10.1002/prca.201400029 · DOI
- Fert-Bober, 2015, Citrullination of myofilament proteins in heart failure, Cardiovasc Res, 108, 232, 10.1093/cvr/cvv185 · DOI · Paper page
- Lindsey, 2015, A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis, J Am Coll Cardiol, 66, 1364, 10.1016/j.jacc.2015.07.035 · DOI · Paper page
- Kerbey, 1976, Biochem J, 154, 327, 10.1042/bj1540327 · DOI · Paper page
- Sharma, 2014, Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling, Cell Rep, 8, 1583, 10.1016/j.celrep.2014.07.036 · DOI · Paper page
- Lundby, 2012, Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues, Nat Commun, 3, 876, 10.1038/ncomms1871 · DOI · Paper page
- Deng, 2011, Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria, Mol Cell Proteomics, 10, 10.1074/mcp.M110.000117 · DOI · Paper page
- Scholten, 2013, Phosphoproteomics study based on in vivo inhibition reveals sites of calmodulin-dependent protein kinase II regulation in the heart, J Am Heart Assoc, 2, e000318, 10.1161/JAHA.113.000318 · DOI
- Kooij, 2013, Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts, J Mol Cell Cardiol, 60, 116, 10.1016/j.yjmcc.2013.04.012 · DOI
- Svinkina, 2015, Deep, quantitative coverage of the lysine acetylome using novel anti-acetyl-lysine antibodies and an optimized proteomic workflow, Mol Cell Proteomics, 14, 2429, 10.1074/mcp.O114.047555 · DOI · Paper page
- Horton, 2016, Mitochondrial protein hyperacetylation in the failing heart, JCI Insight, 2, e84897
- Sun, 2016, Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation, Cardiovasc Res, 110, 96, 10.1093/cvr/cvw037 · DOI
- Sun, 2015, Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria, Cardiovasc Res, 106, 227, 10.1093/cvr/cvv044 · DOI
- Murray, 2013, Quantification of mitochondrial S-nitrosylation by CysTMT6 switch assay, Methods Mol Biol, 1005, 169, 10.1007/978-1-62703-386-2_14 · DOI
- Kim, 2012, Metabolic labeling reveals proteome dynamics of mouse mitochondria, Mol Cell Proteomics, 11, 1586, 10.1074/mcp.M112.021162 · DOI · Paper page
- Price, 2012, Measurement of human plasma proteome dynamics with 2H2O and liquid chromatography tandem mass spectrometry, Anal Biochem, 420, 73, 10.1016/j.ab.2011.09.007 · DOI
- Lam, 2014, Protein kinetic signatures of the remodeling heart following isoproterenol stimulation, J Clin Invest, 124, 1734, 10.1172/JCI73787 · DOI · Paper page
- Lau, 2016, A large dataset of protein dynamics in the mammalian heart proteome, Sci Data, 3, 160015, 10.1038/sdata.2016.15 · DOI · Paper page
- Kolwicz, 2011, Glucose metabolism and cardiac hypertrophy, Cardiovasc Res, 90, 194, 10.1093/cvr/cvr071 · DOI · Paper page
- Hsu, 1998, Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers, Biochemistry, 37, 2251, 10.1021/bi972372z · DOI
- Burgers, 2015, A systematic evaluation of protein kinase A-A-kinase anchoring protein interaction motifs, Biochemistry, 54, 11, 10.1021/bi500721a · DOI
- Aye, 2012, Reorganized PKA-AKAP associations in the failing human heart, J Mol Cell Cardiol, 52, 511, 10.1016/j.yjmcc.2011.06.003 · DOI
- Pankow, 2015, ΔF508 CFTR interactome remodelling promotes rescue of cystic fibrosis, Nature, 528, 510, 10.1038/nature15729 · DOI · Paper page
- Morris, 2014, Affinity purification-mass spectrometry and network analysis to understand protein-protein interactions, Nat Protoc, 9, 2539, 10.1038/nprot.2014.164 · DOI · Paper page
- Waldron, 2016, The cardiac TBX5 interactome reveals a chromatin remodeling network essential for cardiac septation, Dev Cell, 36, 262, 10.1016/j.devcel.2016.01.009 · DOI · Paper page
- Rizzetto, 2015, Qualitative and quantitative protein complex prediction through proteome-wide simulations, PLoS Comput Biol, 11, e1004424, 10.1371/journal.pcbi.1004424 · DOI
- Goldfarb, 2014, Spotlite: web application and augmented algorithms for predicting co-complexed proteins from affinity purification–mass spectrometry data, J Proteome Res, 13, 5944, 10.1021/pr5008416 · DOI
- Gingras, 2007, Analysis of protein complexes using mass spectrometry, Nat Rev Mol Cell Biol, 8, 645, 10.1038/nrm2208 · DOI · Paper page
- Leitner, 2016, Crosslinking and mass spectrometry: an integrated technology to understand the structure and function of molecular machines, Trends Biochem Sci, 41, 20, 10.1016/j.tibs.2015.10.008 · DOI · Paper page
- Percy, 2013, Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma, Proteomics, 13, 2202, 10.1002/pmic.201200316 · DOI
- Goodman, 2016, Aligning statistical and scientific reasoning, Science, 352, 1180, 10.1126/science.aaf5406 · DOI
- de Lemos, 2015, Applying a big data approach to biomarker discovery: running before we walk?, Circulation, 132, 2289, 10.1161/CIRCULATIONAHA.115.019648 · DOI
- Keshishian, 2015, Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury, Mol Cell Proteomics, 14, 1, 10.1074/mcp.M114.046813 · DOI · Paper page
- Yin, 2014, Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative, Arterioscler Thromb Vasc Biol, 34, 939, 10.1161/ATVBAHA.113.302918 · DOI
- Addona, 2011, A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease, Nat Biotechnol, 29, 635, 10.1038/nbt.1899 · DOI · Paper page
- Kong, 2010, Heart failure-associated changes in RNA splicing of sarcomere genes, Circ Cardiovasc Genet, 3, 138, 10.1161/CIRCGENETICS.109.904698 · DOI · Paper page
- Song, 2012, Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy, PLoS One, 7, e35552, 10.1371/journal.pone.0035552 · DOI · Paper page
- Hebert, 2013, Neutron-encoded mass signatures for multiplexed proteome quantification, Nat Methods, 10, 332, 10.1038/nmeth.2378 · DOI · Paper page
- Stubbs, 1998, Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes, Eur Heart J, 19, 1355, 10.1053/euhj.1998.1043 · DOI
- de Lemos, 2003, B-type natriuretic peptide in cardiovascular disease, Lancet, 362, 316, 10.1016/S0140-6736(03)13976-1 · DOI · Paper page
- Puleo, 1990, Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB, Circulation, 82, 759, 10.1161/01.CIR.82.3.759 · DOI · Paper page
- Shlipak, 2005, Cystatin C and the risk of death and cardiovascular events among elderly persons, N Engl J Med, 352, 2049, 10.1056/NEJMoa043161 · DOI · Paper page
- Daniels, 2008, Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study, J Am Coll Cardiol, 51, 913, 10.1016/j.jacc.2007.10.048 · DOI
- Brennan, 2003, Prognostic value of myeloperoxidase in patients with chest pain, N Engl J Med, 349, 1595, 10.1056/NEJMoa035003 · DOI · Paper page
- Kavsak, 2007, Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction, Clin Chim Acta, 380, 213, 10.1016/j.cca.2007.01.001 · DOI
- Johnson, 2004, Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE), Circulation, 109, 726, 10.1161/01.CIR.0000115516.54550.B1 · DOI · Paper page
- Adams, 1993, Cardiac troponin I. A marker with high specificity for cardiac injury, Circulation, 88, 101, 10.1161/01.CIR.88.1.101 · DOI · Paper page
- Reichlin, 2009, Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N Engl J Med, 361, 858, 10.1056/NEJMoa0900428 · DOI · Paper page
- Danese, 2016, An historical approach to the diagnostic biomarkers of acute coronary syndrome, Ann Transl Med, 4, 194, 10.21037/atm.2016.05.19 · DOI · Paper page
- Ladenson, 2007, A personal history of markers of myocyte injury [myocardial infarction], Clin Chim Acta, 381, 3, 10.1016/j.cca.2007.02.039 · DOI
- Eng, 1994, An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database, J Am Soc Mass Spectrom, 5, 976, 10.1016/1044-0305(94)80016-2 · DOI · Paper page
Cited by
Atlas of the plasma proteome in health and disease in 53,026 adults
Deng, Y.-T., You, J., He, Y., Zhang, Y., Li, H.-Y., Wu, X.-R., Cheng, J.-Y., Guo, Y., Long, Z.-W., Chen, Y.-L., et al. (2025) · Cell · doi:10.1016/j.cell.2024.10.045 · Cited by 294
Roberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome
Arrell, D. K., Rosenow, C. S., Yamada, S., Behfar, A., & Terzic, A. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-0091-6 · Cited by 30
Cell-cell interactions in the heart: advanced cardiac models and omics technologies
Tan, S., Yang, J., Hu, S., & Lei, W. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03982-z · Cited by 30
Metadata
- Authors
- Lam, M. P. Y., Ping, P., & Murphy, E.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 68
- Issue
- 25
- Pages
- 2819-2830
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2563609186
- Cited by
- 105
- References
- 19
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 391 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.